MA28680B1 - 3-aminocyclopentanecarboxamides utiles comme modulateurs de récepteurs de chimiokines - Google Patents
3-aminocyclopentanecarboxamides utiles comme modulateurs de récepteurs de chimiokinesInfo
- Publication number
- MA28680B1 MA28680B1 MA29560A MA29560A MA28680B1 MA 28680 B1 MA28680 B1 MA 28680B1 MA 29560 A MA29560 A MA 29560A MA 29560 A MA29560 A MA 29560A MA 28680 B1 MA28680 B1 MA 28680B1
- Authority
- MA
- Morocco
- Prior art keywords
- chemokine receptors
- modulators
- useful
- aminocyclopentanecarboxamides
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
3-aminocyclopentanecarboxamides utiles comme modulateurs de récepteurs de chimiokines La présente invention concerne des composés de formule (I) : qui sont des modulateurs de récepteurs de chimiokines. Les composés de la présente invention, et des compositions les contenant, sont utiles dans le traitement de maladies en rapport avec l'expression et/ou l'activité de récepteurs de chimiokines.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58348204P | 2004-06-28 | 2004-06-28 | |
US62437404P | 2004-11-01 | 2004-11-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA28680B1 true MA28680B1 (fr) | 2007-06-01 |
Family
ID=35783293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29560A MA28680B1 (fr) | 2004-06-28 | 2006-12-28 | 3-aminocyclopentanecarboxamides utiles comme modulateurs de récepteurs de chimiokines |
Country Status (21)
Country | Link |
---|---|
US (2) | US7449467B2 (fr) |
EP (1) | EP1763351B9 (fr) |
JP (2) | JP4116670B2 (fr) |
KR (1) | KR100856156B1 (fr) |
AP (1) | AP2006003849A0 (fr) |
AR (1) | AR049559A1 (fr) |
AU (1) | AU2005260013A1 (fr) |
BR (1) | BRPI0512352A (fr) |
CA (1) | CA2571019C (fr) |
CR (1) | CR8775A (fr) |
EA (1) | EA011487B1 (fr) |
EC (1) | ECSP067120A (fr) |
ES (1) | ES2614117T3 (fr) |
GE (1) | GEP20094843B (fr) |
IL (1) | IL179910A0 (fr) |
MA (1) | MA28680B1 (fr) |
MX (1) | MXPA06014672A (fr) |
NO (1) | NO20070487L (fr) |
SG (1) | SG156691A1 (fr) |
TW (1) | TW200608966A (fr) |
WO (1) | WO2006004684A2 (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4828829B2 (ja) | 2002-11-27 | 2011-11-30 | インサイト・コーポレイション | ケモカイン受容体のモジュレーターとしての3−アミノピロリジン誘導体 |
EP1734966B1 (fr) * | 2004-04-13 | 2013-07-31 | Incyte Corporation | Utilisation de derives de piperazinylpiperidine comme antagonistes de recepteurs de chimiokines |
KR100856155B1 (ko) * | 2004-06-28 | 2008-09-03 | 인사이트 코포레이션 | 케모카인 수용체의 조절자로서의3-아미노사이클로펜탄카복스아마이드 |
JP4116670B2 (ja) * | 2004-06-28 | 2008-07-09 | インサイト コーポレイション | ケモカイン受容体の調節剤としての3−アミノシクロペンタンカルボキサミド |
WO2007053498A1 (fr) | 2005-11-01 | 2007-05-10 | Millennium Pharmaceuticals, Inc. | Composés pouvant être employés en tant qu'antagonistes de ccr2 |
US8067415B2 (en) | 2005-11-01 | 2011-11-29 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of CCR2 |
MEP1008A (xx) * | 2005-12-21 | 2010-02-10 | Incyte Corp | 3-aminociklopentankarboksamidi kao modulatori receptora hemokina |
US7910108B2 (en) | 2006-06-05 | 2011-03-22 | Incyte Corporation | Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases |
US20080076120A1 (en) * | 2006-09-14 | 2008-03-27 | Millennium Pharmaceuticals, Inc. | Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders |
WO2008109238A1 (fr) * | 2007-03-02 | 2008-09-12 | Janssen Pharmaceutica N.V. | Cyclopentylpipéridines substituées antagonistes du ccr2 |
WO2009015166A1 (fr) | 2007-07-24 | 2009-01-29 | Bristol-Myers Squibb Company | Dérivés de pipéridine en tant que modulateurs d'activité de récepteur de chimiokine |
TWI433838B (zh) | 2008-06-25 | 2014-04-11 | 必治妥美雅史谷比公司 | 作為趨化因子受體活性調節劑之六氫吡啶衍生物 |
PE20110831A1 (es) | 2008-11-26 | 2011-11-20 | Pfizer | 3-aminociclopentanocarboxamidas como moduladores del receptor de quimiocina |
CN101555616B (zh) * | 2009-05-13 | 2012-11-07 | 大连理工大学 | 镍钛合金表面羟基磷灰石/二氧化钛复合涂层的制备方法 |
NZ603478A (en) | 2010-05-12 | 2014-09-26 | Vertex Pharma | 2 -aminopyridine derivatives useful as inhibitors of atr kinase |
WO2013010839A1 (fr) * | 2011-07-15 | 2013-01-24 | Boehringer Ingelheim International Gmbh | Antagonistes de ccr2 nouveaux et sélectifs |
HRP20220522T1 (hr) | 2014-08-04 | 2022-06-10 | Nuevolution A/S | Proizvoljno kondenzirani heterociklil-supstituirani derivati pirimidina koji su korisni za liječenje upalnih, metaboličkih, onkoloških i autoimunih bolesti |
US10403890B2 (en) * | 2015-11-10 | 2019-09-03 | Nissan Motor Co., Ltd. | Negative electrode active material for electric device and electric device using the same |
MX2022007265A (es) | 2019-12-20 | 2022-09-09 | Nuevolution As | Compuestos activos frente a receptores nucleares. |
US11613532B2 (en) | 2020-03-31 | 2023-03-28 | Nuevolution A/S | Compounds active towards nuclear receptors |
MX2022012260A (es) | 2020-03-31 | 2022-11-30 | Nuevolution As | Compuestos activos frente a receptores nucleares. |
WO2022108381A1 (fr) | 2020-11-19 | 2022-05-27 | 주식회사 오에이티씨 | Composition pour la prévention ou le traitement d'une maladie neuro-inflammatoire comprenant de la didanosine |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6500844B1 (en) * | 1999-06-11 | 2002-12-31 | Merck & Co., Inc. | Cyclopentyl modulators of chemokine receptor activity |
US6977265B2 (en) | 2001-11-30 | 2005-12-20 | Roche Palo Alto Llc | Piperidine CCR-3 receptor antagonists |
DE60322877D1 (de) | 2002-04-29 | 2008-09-25 | Merck Sharp & Dohme | Tetrahydropyranylcyclopentyltetrahydroisochino-linmodulatoren der chemokinrezeptoraktivität |
WO2003092586A2 (fr) * | 2002-04-29 | 2003-11-13 | Merck & Co., Inc. | Modulateurs tetrahydropyranyl cyclopentyl tetrahydropyridopyridine de l'activite des recepteurs de chimiokine |
MY129850A (en) * | 2002-04-29 | 2007-05-31 | Merck Sharp & Dohme | Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
EP1558599A4 (fr) | 2002-10-30 | 2007-06-27 | Merck & Co Inc | Modulateurs d'heteroarylpiperidine de l'activite des recepteurs de la chimiokine |
JP2006514618A (ja) | 2002-10-30 | 2006-05-11 | メルク エンド カムパニー インコーポレーテッド | ケモカイン受容体活性のピペリジニル−アルファ−アミノアミドモジュレーター |
EP1558576A4 (fr) | 2002-10-30 | 2008-04-16 | Merck & Co Inc | Composes de piperidinyl cyclopentyl aryl benzylamide modulateurs de l'activite du recepteur de chimiokine |
CA2502174A1 (fr) * | 2002-10-30 | 2004-05-21 | Merck & Co., Inc. | Modulateurs de l'activite des recepteurs de la chimiokine a base de tetrahydropyranyl-cyclopentyl-benzylamide |
JP2006511500A (ja) | 2002-10-30 | 2006-04-06 | メルク エンド カムパニー インコーポレーテッド | γ−アミノアミド系のケモカイン受容体活性調節剤 |
JP4828829B2 (ja) | 2002-11-27 | 2011-11-30 | インサイト・コーポレイション | ケモカイン受容体のモジュレーターとしての3−アミノピロリジン誘導体 |
AU2003287917A1 (en) * | 2002-12-20 | 2004-07-14 | Leo Pharma A/S | Novel aminobenzophenone compounds |
US20050192286A1 (en) | 2003-10-22 | 2005-09-01 | Neurocrine Biosciences, Inc. | Ligands of melanocortin receptors and compositions and methods related thereto |
ATE517622T1 (de) | 2003-10-27 | 2011-08-15 | Merck Sharp & Dohme | Salz eines tetrahydropyranylcyclopentyltetrahydropyridopyr diderivats als ccr-2 antagonisten |
EP1708703A4 (fr) * | 2003-12-11 | 2008-04-09 | Anormed Inc | Composes de liaison aux recepteurs de la chemokine |
CN102344398B (zh) | 2003-12-18 | 2015-02-25 | 因赛特公司 | 作为趋化因子受体调控剂的3-环烷基氨基吡咯烷衍生物 |
US20070117797A1 (en) | 2004-01-02 | 2007-05-24 | Goble Stephen D | Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
AU2005206791A1 (en) | 2004-01-20 | 2005-08-04 | Merck Sharp & Dohme Corp. | 2,6-disubstituted piperidines as modulators of chemokine receptor activity |
AU2005208887B2 (en) | 2004-01-28 | 2010-02-25 | Merck Sharp & Dohme Corp. | Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
CN1946696A (zh) | 2004-04-26 | 2007-04-11 | 默克公司 | 四氢吡喃基环戊基1-取代的和1,1-二取代的四氢异喹啉趋化因子受体活性调节剂 |
WO2005115392A2 (fr) | 2004-05-11 | 2005-12-08 | Incyte Corporation | 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides utilises comme modulateurs des recepteurs de la chimiokine |
JP4116670B2 (ja) * | 2004-06-28 | 2008-07-09 | インサイト コーポレイション | ケモカイン受容体の調節剤としての3−アミノシクロペンタンカルボキサミド |
KR100856155B1 (ko) | 2004-06-28 | 2008-09-03 | 인사이트 코포레이션 | 케모카인 수용체의 조절자로서의3-아미노사이클로펜탄카복스아마이드 |
PA8653301A1 (es) | 2004-11-22 | 2006-11-09 | Incyte Corp Incyte Corp | Sales de la n-[2-({(3r)-1-[trans-4-hidroxi-4-(6-metoxipiridin-3-il) ciclohexil)pirrolidin |
MEP1008A (xx) | 2005-12-21 | 2010-02-10 | Incyte Corp | 3-aminociklopentankarboksamidi kao modulatori receptora hemokina |
-
2005
- 2005-06-27 JP JP2007518357A patent/JP4116670B2/ja not_active Expired - Fee Related
- 2005-06-27 SG SG200907284-4A patent/SG156691A1/en unknown
- 2005-06-27 CA CA2571019A patent/CA2571019C/fr not_active Expired - Fee Related
- 2005-06-27 TW TW094121454A patent/TW200608966A/zh unknown
- 2005-06-27 ES ES05790938.4T patent/ES2614117T3/es active Active
- 2005-06-27 KR KR1020067027464A patent/KR100856156B1/ko not_active IP Right Cessation
- 2005-06-27 EP EP05790938.4A patent/EP1763351B9/fr active Active
- 2005-06-27 AU AU2005260013A patent/AU2005260013A1/en not_active Abandoned
- 2005-06-27 EA EA200602242A patent/EA011487B1/ru not_active IP Right Cessation
- 2005-06-27 MX MXPA06014672A patent/MXPA06014672A/es unknown
- 2005-06-27 BR BRPI0512352-6A patent/BRPI0512352A/pt not_active IP Right Cessation
- 2005-06-27 US US11/167,816 patent/US7449467B2/en active Active
- 2005-06-27 GE GEAP20059758A patent/GEP20094843B/en unknown
- 2005-06-27 WO PCT/US2005/022793 patent/WO2006004684A2/fr active Application Filing
- 2005-06-27 AP AP2006003849A patent/AP2006003849A0/xx unknown
- 2005-06-28 AR ARP050102676A patent/AR049559A1/es unknown
-
2006
- 2006-11-28 CR CR8775A patent/CR8775A/es not_active Application Discontinuation
- 2006-12-07 IL IL179910A patent/IL179910A0/en unknown
- 2006-12-27 EC EC2006007120A patent/ECSP067120A/es unknown
- 2006-12-28 MA MA29560A patent/MA28680B1/fr unknown
-
2007
- 2007-01-25 NO NO20070487A patent/NO20070487L/no not_active Application Discontinuation
- 2007-12-12 JP JP2007321252A patent/JP2008074877A/ja active Pending
-
2008
- 2008-09-25 US US12/238,121 patent/US8470827B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP4116670B2 (ja) | 2008-07-09 |
WO2006004684A2 (fr) | 2006-01-12 |
SG156691A1 (en) | 2009-11-26 |
EP1763351A2 (fr) | 2007-03-21 |
TW200608966A (en) | 2006-03-16 |
US20100119503A1 (en) | 2010-05-13 |
KR100856156B1 (ko) | 2008-09-03 |
AR049559A1 (es) | 2006-08-16 |
GEP20094843B (en) | 2009-11-25 |
AP2006003849A0 (en) | 2006-12-31 |
AU2005260013A1 (en) | 2006-01-12 |
EP1763351A4 (fr) | 2009-08-12 |
EA200602242A1 (ru) | 2007-04-27 |
CR8775A (es) | 2007-01-04 |
EP1763351B1 (fr) | 2016-11-30 |
US7449467B2 (en) | 2008-11-11 |
IL179910A0 (en) | 2007-05-15 |
JP2008504293A (ja) | 2008-02-14 |
MXPA06014672A (es) | 2007-03-26 |
BRPI0512352A (pt) | 2008-03-04 |
CA2571019C (fr) | 2012-06-05 |
JP2008074877A (ja) | 2008-04-03 |
EP1763351B9 (fr) | 2017-05-31 |
ECSP067120A (es) | 2007-01-26 |
ES2614117T3 (es) | 2017-05-29 |
NO20070487L (no) | 2007-03-05 |
WO2006004684A8 (fr) | 2007-01-04 |
US20060004018A1 (en) | 2006-01-05 |
EA011487B1 (ru) | 2009-04-28 |
KR20070026660A (ko) | 2007-03-08 |
CA2571019A1 (fr) | 2006-01-12 |
WO2006004684A3 (fr) | 2006-10-05 |
US8470827B2 (en) | 2013-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA28680B1 (fr) | 3-aminocyclopentanecarboxamides utiles comme modulateurs de récepteurs de chimiokines | |
MA28681B1 (fr) | 3-aminocyclopentanecarboxamides utiles comme modulateurs de récepteurs de chimiokines | |
MA30077B1 (fr) | 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines | |
TNSN06368A1 (fr) | 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines | |
MA27728A1 (fr) | Antagonistes des recepteurs de cgrp | |
TNSN03143A1 (fr) | Ligands de recepteurs de 5-ht et leurs utilisations . | |
MA31906B1 (fr) | Inhibiteurs de la replication du virus de limmunodeficience humaine | |
MA30333B1 (fr) | Aminotetrahydropyranes utiles en tant qu'inhibiteurs de la dipeptidyle peptidase-iv pour le traitement ou la prevention du diabete. | |
TNSN05121A1 (fr) | Purines et leurs utilisations comme ligands des recepteurs de cannabinoides | |
EA200700934A1 (ru) | Производные пиримидина и их применение в качестве модуляторов cb2 | |
MA33155B1 (fr) | Composes organiques et leurs utilisations | |
TN2009000138A1 (fr) | Biaryl-ether-urees | |
MA29693B1 (fr) | Derives de xanthine en tant qu'agonistes hm74a selectifs | |
MA34650B1 (fr) | Antagonistes du récepteur cgrp de pipéridinone carboxamide azaindane | |
MA31158B1 (fr) | Composes tricycliques et leur utilisation comme modulateurs du recepteur de glucocorticoïdes | |
MA27119A1 (fr) | Modulateurs tetrahydropyranyle cyclopentyle tetrahydropyrido pyridine de l'activite d'un recepteur de chimiokine | |
MA27565A1 (fr) | Derives de 4-tetrazolyl-4-phenylpiperidine utilises pour le traitement de la douleur | |
TNSN02021A1 (fr) | Derives de benzimidazole nouveaux, et compositions les contenant | |
EA200501504A1 (ru) | Лиганды каннабиноидных рецепторов и их применение | |
TNSN05190A1 (fr) | DERIVES DE PYRAZOLO [1,5-a][1,3,5] TRIAZINE SERVANT DE LIGANDS DES RECEPTEURS DE CANNABINOIDES | |
BG66080B1 (bg) | Заместени тиоацетамиди | |
MA28286A1 (fr) | Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant | |
MA29694B1 (fr) | Derives de l'imidazopyridine comme ligands du recepteur cannabinoide | |
MA31562B1 (fr) | Macrocycles et leurs utilisations | |
TNSN06444A1 (fr) | 3-aminocyclopentanecarboxamides utiles comme modulateurs de recepteurs de chimiokines |